Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting (TEASP6PPONV)
Postoperative Nausea and Vomiting
About this trial
This is an interventional prevention trial for Postoperative Nausea and Vomiting focused on measuring Postoperative nausea and vomiting, Transcutaneous electrical acupoint stimulation, Gynecological laparoscopic surgery, Tropisetron, Dexamethasone
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status I or II
- aged between 18 to 60yr
- scheduled for elective gynecological laparoscopic surgery requiring general anesthesia
Exclusion Criteria:
- pregnancy or breastfeeding
- mental retardation
- psychiatric or neurological disease
- use of antiemetics, emetogenic drugs, opioids or glucocorticosteroids within 3 days prior to surgery
- known allergy to tropisetron or dexamethasone
- nausea and/or vomiting within 24 hr prior to surgery
- implantation of a cardiac pacemaker, cardioverter, or defibrillator
- any skin problem at the acupoint stimulation area
Sites / Locations
- Department of Anesthesiology, North Institute of Huashan Hospital,Fudan University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Sham Comparator
Acustimulation
Tropisetron
Control
Transcutaneous electrical acupoint stimulation (TEAS) starts 30 min before surgery and lasts until patient leaves the postanesthetic care unit.Dexamethasone 10mg i.v. after induction.
Tropisetron 5mg iv. at the start of skin closure.Sham transcutaneous electrical acupoint stimulation.Dexamethasone 10mg i.v.after induction.
Sham transcutaneous electrical acupoint stimulation. Dexamethasone 10mg i.v.after induction.